Similar to the reports in breast and prostate cancer, where PMD-026 efficiently induced apoptosis in the tumor cells [31, 32, 34], RSK inhibition potently enhanced the sub-G1 cell cycle fraction as well as the protein levels of the pro-apoptotic Bim in the majority of melanoma cell lines. This evidence concerns the gene RPS6KA3 and prostate carcinoma.